Related Experiment Video
Updated: Jun 5, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Retinopathy of prematurity--epidemics, incidence, prevalence, blindness
1Faculty of Medicine, Comenius University, Bratislava, Slovakia. kvetagergely@seznam.ez
Insights
Premature infants require specialized neonatal care, with Retinopathy of Prematurity (ROP) affecting 5-8% in developed nations. Lower-income countries face a "third ROP epidemic" due to limited resources, leading to higher ROP prevalence up to 30%.
Area of Science:
- Neonatology
- Ophthalmology
- Public Health
Background:
- Developed countries possess advanced neonatal resources for premature infants, yet Retinopathy of Prematurity (ROP) affects 5-8%.
- Economically developing nations experience a rise in premature births but lack sufficient funding for optimal neonatal care.
- This disparity contributes to a significant increase in ROP prevalence, termed the "third ROP epidemic".
Purpose of the Study:
- To analyze the global disparities in neonatal care resources and their impact on Retinopathy of Prematurity (ROP) prevalence.
- To investigate the correlation between economic development, healthcare funding, and the incidence of ROP in premature infants.
Main Methods:
- Comparative analysis of ROP prevalence rates across countries with varying economic development and healthcare funding.
- Review of medical literature and statistical data on premature infant survival and ROP incidence.
- Examination of the relationship between birth weight, gestational age, and ROP severity.
Main Results:
- ROP prevalence is significantly higher in countries with limited financial resources for neonatal care (up to 30%) compared to developed nations (5-8%).
- Premature infants in ROP-affected groups exhibit lower birth weight and gestational age.
- Increased survival of extremely immature newborns correlates with a higher risk of advanced ROP stages.
Conclusions:
- Healthcare resource allocation critically influences ROP outcomes in premature infants globally.
- The
- third ROP epidemic
- highlights the urgent need for improved neonatal care infrastructure in developing economies.
- Gestational age and birth weight are key indicators for ROP risk, necessitating tailored preventative strategies.
Abstract:
Currently, there are enough financial resources in industrial most developed countries to provide quality health care to the risk population of premature children. Neonatological units are equipped with state-of-the-art technological background, and highly qualified personnel are employed at the units. This as well allows providing optimum care of extremely immature newborns. ROP prevalence in these countries reaches approximately 5-8%. Today, a boom of surviving premature newborns can be seen in countries with medium-developed economy. Nevertheless, limited financing resources do not allow for standard high-level care. In such countries, the prevalence reaches up to 30%. In this respect, the "third ROP epidemic" is mentioned. Birth weight and gestational age parameters achieve significantly lower values in ROP-infants than in those not affected by the disease. Higher number of surviving immature newborns correlates with an increased risk of advanced ROP stages occurrence, while the frequency and degree of the disease are of inverse nature to the gestational age and birth weight (Tab. 1, Ref. 39).
Related Concept Videos
Diabetic Retinopathy
Photoreceptors and Visual Pathways
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Glaucoma: Overview
The Retina

